Stomach cancer screening isn’t part of routine checkups in the United States or most Western countries, so if you’re looking into it, you likely fall into one of two categories: you have risk factors that concern you, or you live in (or come from) a region where stomach cancer is more common. The approach depends heavily on which group you’re in. In countries like South Korea and Japan, where stomach cancer rates are high, population-wide screening programs have cut mortality dramatically. Elsewhere, screening is targeted to people at elevated risk.
Who Should Be Screened
Stomach cancer screening makes the most sense when your baseline risk is meaningfully higher than average. The biggest single risk factor is chronic infection with H. pylori, the bacterium that causes ulcers and long-term stomach inflammation. A 15-year follow-up study found that men with H. pylori had roughly six times the risk of developing stomach cancer compared to men with healthy stomach lining. That elevated risk applied regardless of where in the stomach the cancer appeared.
Other factors that raise your risk include a family history of stomach cancer (especially a first-degree relative), a personal history of stomach polyps or chronic atrophic gastritis, heavy smoking, and high intake of salted or smoked foods. People of East Asian, Eastern European, or Central and South American descent also carry higher baseline risk.
The most urgent screening applies to people with inherited gene mutations. Carriers of a CDH1 gene variant linked to hereditary diffuse gastric cancer are advised to consider preventive removal of the entire stomach, typically between ages 20 and 30, regardless of what an endoscopy shows. Those who decline or delay surgery should get yearly endoscopies performed by specialists experienced with this condition. For families with a pattern of stomach cancer but no identified gene mutation, surveillance typically starts at age 40, or 10 years before the youngest case in the family, with a minimum starting age of 18.
Upper Endoscopy: The Primary Screening Tool
The most direct way to screen for stomach cancer is an upper endoscopy, where a thin, flexible tube with a camera is guided through your mouth into your stomach. This lets the doctor visually inspect the stomach lining and take small tissue samples (biopsies) from anything suspicious. It’s the gold standard, but it’s not perfect. Studies report that endoscopy misses gastric cancer somewhere between 5% and 26% of the time, depending on the stage of cancer, the experience of the endoscopist, and how thoroughly the exam is performed.
In countries with organized screening programs, endoscopy has produced striking results. Japan attributed a 57% reduction in stomach cancer deaths to endoscopic screening. South Korea saw early-stage detection rates climb from about 29% in 1995 to 58% by 2007, and overall stomach cancer deaths dropped by more than 80% between 1990 and 2019. The difference between these outcomes and the miss rates above comes down to systematic protocols: standardized examination techniques, experienced specialists, and regular screening intervals.
What to Expect During the Procedure
An upper endoscopy is an outpatient procedure that typically takes 15 to 30 minutes. You’ll receive sedation, so you won’t feel discomfort during the exam and likely won’t remember it afterward. Preparation is straightforward: stop anti-inflammatory pain relievers like ibuprofen five days beforehand, don’t eat solid food after midnight the night before, and have nothing to eat or drink for at least eight hours before the procedure. Regular acetaminophen is fine. You can take essential medications up to four hours before with small sips of water, but skip antacids.
Complications are rare. Perforation (a small tear) occurs in fewer than 1 in 2,500 diagnostic procedures. Clinically significant bleeding after biopsies is exceedingly uncommon, even when multiple samples are taken. You’ll need someone to drive you home because of the sedation, and you may have a mild sore throat for a day or two.
Blood Tests That Flag Risk
Not everyone needs to go straight to endoscopy. Blood-based tests can help identify people whose stomachs show signs of damage that precedes cancer, narrowing down who actually needs the scope.
The most established blood test measures pepsinogen, a protein your stomach produces. Two types are measured and compared as a ratio. When pepsinogen I drops below 25 ng/mL and the ratio of pepsinogen I to pepsinogen II falls below 3.0, it’s a strong signal that the stomach lining has thinned (atrophic gastritis), a known precursor to cancer. Using both cutoffs together, studies have found 90% sensitivity and 100% specificity for detecting atrophic gastritis, meaning the test catches most people with the condition and rarely flags someone who doesn’t have it. An abnormal result doesn’t mean you have cancer. It means your stomach lining has changed enough to warrant an endoscopy.
H. pylori testing is the other key blood test. Since H. pylori infection is the dominant modifiable risk factor, a simple antibody blood test, stool test, or breath test can determine whether you’re infected. If positive, treatment to eradicate the bacteria can significantly reduce your future risk.
Blood Tests for Early Cancer Detection
A newer category of blood tests looks for traces of cancer DNA circulating in the bloodstream. These are still moving toward clinical use, but the results are promising. One plasma-based test targeting specific DNA methylation patterns achieved 87% sensitivity and 90% specificity for detecting stomach cancer. For stage I disease specifically, sensitivity was about 82%, meaning it caught more than four out of five early-stage cancers. That dramatically outperformed the traditional blood tumor marker CEA, which detected only 10% of cases.
These tests work by identifying chemical tags on fragments of DNA that tumor cells shed into the blood. They aren’t yet standard practice for screening, but they represent a potential path toward simpler, less invasive detection, particularly for people who are reluctant to undergo endoscopy or who need monitoring between procedures.
How AI Is Changing Endoscopy
One reason endoscopy miss rates have historically been high is that early stomach cancer can look subtle, even to trained eyes. Artificial intelligence systems are now being tested as a real-time second opinion during procedures. When endoscopists used AI assistance during screening, their overall diagnostic accuracy jumped from about 75% to 87%. The biggest improvements came in detecting precancerous changes: accuracy for dysplasia (abnormal cells that can become cancer) improved by nearly 14 percentage points, and accuracy for intestinal metaplasia (a change in the stomach lining type) improved by over 16 points.
AI assistance is particularly valuable because these precancerous conditions are exactly the stages where detection matters most. Catching dysplasia or metaplasia before it progresses to cancer is the whole point of screening. These AI tools are already being integrated into endoscopy systems at major medical centers.
Screening Approaches by Risk Level
Your screening path depends on where you fall on the risk spectrum:
- Average risk, no symptoms: Routine stomach cancer screening is not recommended in the U.S. or Europe. Testing for H. pylori is reasonable if you have risk factors for infection, such as living in a high-prevalence region or having a family member with stomach cancer.
- Moderate risk (H. pylori infection, family history, atrophic gastritis): H. pylori eradication if infected, pepsinogen blood testing to assess stomach lining health, and endoscopy if blood tests are abnormal or symptoms develop. The interval for repeat screening depends on findings.
- High risk (hereditary syndromes, CDH1 or CTNNA1 gene mutations): Yearly endoscopy at a specialized center, with serious consideration of preventive stomach removal. For CDH1 carriers, this conversation should happen between ages 20 and 30. Surveillance in carriers older than 70 is generally not considered beneficial.
If you’re of East Asian descent living in a Western country, you may carry risk levels closer to those in high-incidence regions, even though your country’s guidelines don’t call for routine screening. Discussing your background with a gastroenterologist can help determine whether proactive screening makes sense for you.